Stock Analysis of Anebulo Pharmaceuticals Inc (ANEB) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code ANEB
Close 2.05
Change -0.050 / 2.38 %
Volume 1131.00
Vol Change 523.00 / 86.02 %
IndustryBiotechnology
SectorHealthcare
AIO Strength Index
Technical StrengthBearish
Growth Index No Significant Growth
Value Index Poor Value Stock
Profitability Index Poor Profitability Stock
Stability Index Excellent Stability


Fundamental View of Anebulo Pharmaceuticals Inc
PE (TTM)

-5.65

Very Poor
Price / Book

6.09

Very Poor
Price / Sales

0

Very Poor
Piotroski F Score

1.0

Very Poor
Market Cap

53163.06 K

Enterprise Value

41915.66 K

ROA (TTM)

-96.07

Very Poor
ROE (TTM)

-107.82

Very Poor
Net Margin (TTM)

0

Poor
Revenue

%

0
Net Profit

71.89 %

-11732.34 K
Debt to Equity

0

Excellent
Altman Z Score

19.66

Excellent
Quick Ratio

0

Poor
Cash Ratio

21.04

Excellent


Highs/Lows of Anebulo Pharmaceuticals Inc
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week2.115 3.07 % 0.513 % 2.18092.0528-May-2431-May-24
Two Week2.2999 10.87 % 0.486 % 2.262.0520-May-2431-May-24
One Month2.9 29.31 % 4.80 % 3.22.0502-May-2431-May-24
Three Month2.72 24.63 % 3.56 % 3.32.0518-Apr-2431-May-24
Six Months2.28 10.09 % 15.54 % 3.31.8718-Apr-2414-Dec-23
One year2.26 9.29 % 26.26 % 4.051.6212-Sep-2316-Oct-23
Two year2.7 24.07 % 27.72 % 4.051.6212-Sep-2316-Oct-23


Technical View of Anebulo Pharmaceuticals Inc
RSI

33.93

Neutral
MACD

-0.197

Bearish
ADX

26.34

Mild Bearish
Super Trend

2.55

Mild Bearish
Williams %R

-100.00

Mild Bullish
CCI

-76.24

Neutral


EMA 5

2.09

Mild Bearish
EMA 15

2.26

Mild Bearish
EMA 50

2.53

Strong Bearish
EMA 100

2.57

Bearish
SMA 100

2.62

Strong Bearish
SMA 200

2.59

Strong Bearish
SMA 5 / 20

2.08 / 2.43

Mild Bearish
SMA 15 / 50

2.24 / 2.65

Bearish
SMA 50 / 200

2.65 / 2.59

Mild Bullish




Charts of Anebulo Pharmaceuticals Inc


Returns of Anebulo Pharmaceuticals Inc with Peers
Period / StockANEBEARRMTIDRRX
1 Week-3.07%-2.28%-3.04%31.54%
1 Mth-29.31%-1.15%20.21%78.20%
3 Mth-24.63%0.391%24.47%71.00%
6mth-10.09%-22.24%-1.68%175.81%
1 Year-9.29%-69.87%-47.14%-72.20%
2 Year-24.07%-97.61%7.01%-68.91%
5 Years---96.53%-68.69%
charts-
View All Together in Chart      Inline           Tile

Compare Fundamentals of Anebulo Pharmaceuticals Inc with Peers
Ratio / StockANEBEARRMTIDRRX
PE-5.65-235.42-968.28-2.06
P/B6.09796.50476.664.04
ROA-96.07-163.69-17.99-47.87
ROE-107.82-338.33-49.23-196.44
Debt To Equity000.4921.22
Revenue0
% 		41108.00 K
10.36 % 		80832.00 K
11.02 % 		9194.00 K
52.32 %
Net Income-11732.34 K
71.89 % 		-108173.00 K
31.31 % 		-9289.00 K
50.27 % 		-36652.00 K
3.73 %


Technicals of Anebulo Pharmaceuticals Inc with Peers
Technical / StockANEBEARRMTIDRRX-
ADX26.3423.9044.8226.01
CMF-0.542-0.2080.1670.364
MFI18.6916.0058.0585.29
RSI33.9341.0358.2574.71
MACD Abv SignalFalseFalseFalseTrue
Price Above 50 MAFalseFalseTrueTrue-
Price Above 200 MAFalseFalseTrueTrue-


About : Anebulo Pharmaceuticals Inc

Address : 1017 Ranch Road 620 South, Lakeway, TX, United States, 78734
Tel : (512) 598-0931
URL : https://www.anebulo.com
Code : ANEB, ISIN : US0345691036, Exchange : NASDAQ, Country : USA
Fiscal Year End : December
IPO date : 07_May_2021
Employee Count : 2

Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing solutions for people suffering from acute cannabinoid intoxication (ACI) and substance addiction. The company's lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist, which is in a Phase II clinical trial to address the unmet medical need for a specific antidote for ACI. Anebulo Pharmaceuticals, Inc. was incorporated in 2020 and is based in Lakeway, Texas.


Note : All Data Generated at the End of Trading Hours (EOD Data)